URGN Insider Trading

Insider Ownership Percentage: 5.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $405,360.32

UroGen Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at UroGen Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

UroGen Pharma Share Price & Price History

Current Price: $11.86
Price Change: Price Decrease of -0.3 (-2.47%)
As of 11/14/2024 01:00 AM ET

This chart shows the closing price history over time for URGN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

UroGen Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/9/2024Jason Drew SmithGeneral CounselSell1,521$13.08$19,894.6825,226View SEC Filing Icon  
9/9/2024Mark SchoenbergInsiderSell859$13.08$11,235.72145,091View SEC Filing Icon  
6/10/2024Mark SchoenbergInsiderSell5,153$13.08$67,401.24144,284View SEC Filing Icon  
3/18/2024Mark SchoenbergInsiderSell12,000$14.05$168,600.00139,437View SEC Filing Icon  
1/31/2024Jason Drew SmithGeneral CounselSell4,993$15.74$78,589.8218,824View SEC Filing Icon  
1/31/2024Mark SchoenbergInsiderSell3,789$15.74$59,638.86149,423View SEC Filing Icon  
8/31/2023Jason Drew SmithGeneral CounselSell3,800$18.01$68,438.0018,407View SEC Filing Icon  
1/31/2023Jason Drew SmithGeneral CounselSell1,636$10.12$16,556.3212,600View SEC Filing Icon  
1/31/2023Mark SchoenbergInsiderSell1,900$10.12$19,228.00146,879View SEC Filing Icon  
10/31/2022Mark SchoenbergInsiderSell258$11.85$3,057.3023,950View SEC Filing Icon  
8/1/2022Mark SchoenbergInsiderSell259$7.81$2,022.7923,708View SEC Filing Icon  
4/30/2022Mark SchoenbergInsiderSell254$6.62$1,681.4823,467View SEC Filing Icon  
1/31/2022Elizabeth A. BarrettCEOSell8,195$7.58$62,118.10View SEC Filing Icon  
1/31/2022Jason Drew SmithGeneral CounselSell414$7.58$3,138.12View SEC Filing Icon  
1/31/2022Mark SchoenbergInsiderSell1,374$7.58$10,414.92View SEC Filing Icon  
1/31/2022Molly HendersonCFOSell331$7.58$2,508.98View SEC Filing Icon  
1/26/2022Mark SchoenbergInsiderSell111$8.09$897.99View SEC Filing Icon  
1/4/2022Elizabeth A. BarrettCEOSell46,968$9.15$429,757.20View SEC Filing Icon  
11/30/2021Jason Drew SmithGeneral CounselSell3,803$12.03$45,750.09View SEC Filing Icon  
11/30/2021Molly HendersonCFOSell2,587$12.03$31,121.61View SEC Filing Icon  
11/18/2021Mark SchoenbergInsiderBuy160$13.10$2,096.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for UroGen Pharma (NASDAQ:URGN)

91.29% of UroGen Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at URGN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

UroGen Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2024Verition Fund Management LLC13,254$0.17M0.0%N/A0.057%Search for SEC Filing on Google Icon
11/14/2024Vestal Point Capital LP400,000$5.08M0.4%N/A1.705%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1,341,072$17.03M0.0%+1.6%5.718%Search for SEC Filing on Google Icon
11/14/2024Stonepine Capital Management LLC280,345$3.56M2.2%N/A1.195%Search for SEC Filing on Google Icon
11/13/2024Great Point Partners LLC758,786$9.64M2.8%-73.9%3.235%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets8,546$0.11M0.0%+221.8%0.036%Search for SEC Filing on Google Icon
11/13/2024FMR LLC23,090$0.29M0.0%+575.1%0.098%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.90,493$1.15M0.0%+9.1%0.386%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC12,203$0.16M0.0%N/A0.052%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP19,597$0.25M0.0%N/A0.084%Search for SEC Filing on Google Icon
10/31/2024ARK Investment Management LLC121,634$1.55M0.0%-19.9%0.519%Search for SEC Filing on Google Icon
10/28/2024Oak Ridge Investments LLC76,799$0.98M0.1%-3.9%0.327%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC271,897$3.45M0.2%+273.6%1.159%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.8,100$0.10M0.0%+90.9%0.035%Search for SEC Filing on Google Icon
10/11/2024Wesbanco Bank Inc.74,400$0.95M0.0%N/A0.317%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC14,062$0.18M0.0%N/A0.060%Search for SEC Filing on Google Icon
8/16/2024Coastal Bridge Advisors LLC38,500$0.65M0.2%+4.1%0.164%Search for SEC Filing on Google Icon
8/16/2024Annandale Capital LLC75,552$1.27M0.2%-7.4%0.322%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company13,302$0.22M0.0%-59.1%0.057%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC1,160,899$19.48M0.0%+2,672.0%4.951%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC30,290$0.51M0.0%-28.3%0.129%Search for SEC Filing on Google Icon
8/14/2024Point72 Asset Management L.P.2,449,277$41.10M0.1%+120.3%10.445%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC44,949$0.75M0.0%+630.9%0.192%Search for SEC Filing on Google Icon
8/14/2024Great Point Partners LLC2,906,259$48.77M9.3%+10.9%12.393%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP42,841$0.72M0.0%N/A0.183%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC11,888$0.20M0.0%N/A0.051%Search for SEC Filing on Google Icon
8/8/2024Main Street Financial Solutions LLC24,000$0.40M0.0%N/A0.102%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC72,787$1.22M0.1%+3.4%0.310%Search for SEC Filing on Google Icon
8/7/2024Cowen AND Company LLC2,099,482$35.23M1.0%+29.1%8.953%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers50,477$0.85M0.0%+37.2%0.215%Search for SEC Filing on Google Icon
7/26/2024ARK Investment Management LLC151,781$2.55M0.0%+3.7%0.647%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp96,619$1.62M0.0%+41.6%0.412%Search for SEC Filing on Google Icon
7/22/2024Harel Insurance Investments & Financial Services Ltd.463,565$7.78M0.1%-31.2%1.977%Search for SEC Filing on Google Icon
7/17/2024Oak Ridge Investments LLC79,929$1.34M0.1%+30.6%0.341%Search for SEC Filing on Google Icon
7/16/2024Shikiar Asset Management Inc.10,750$0.18M0.0%-67.7%0.046%Search for SEC Filing on Google Icon
5/29/2024Opaleye Management Inc.270,000$4.05M0.9%-15.6%1.151%Search for SEC Filing on Google Icon
5/17/2024Tidal Investments LLC28,320$0.43M0.0%N/A0.121%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System2,788$42K0.0%-37.7%0.012%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD267,143$4.01M0.0%N/A1.139%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.194,966$2.92M0.0%+14.3%0.831%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets39,795$0.60M0.0%+73.1%0.170%Search for SEC Filing on Google Icon
5/1/2024Oak Ridge Investments LLC61,204$0.92M0.1%N/A0.261%Search for SEC Filing on Google Icon
4/30/2024Harel Insurance Investments & Financial Services Ltd.673,487$10.10M0.2%-22.6%2.872%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.5,903$89K0.0%+65.1%0.025%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP104,600$1.57M0.0%+49.3%0.446%Search for SEC Filing on Google Icon
2/22/2024Sierra Summit Advisors LLC14,515$0.22M0.1%N/A0.062%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC175,500$2.63M0.4%+20.8%0.748%Search for SEC Filing on Google Icon
2/14/2024Superstring Capital Management LP255,430$3.83M2.7%N/A1.089%Search for SEC Filing on Google Icon
2/14/2024RTW Investments LP1,726,808$25.90M0.4%+101.4%7.364%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 1,691$25K0.0%-83.7%0.007%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC33,320$0.50M0.0%+12.6%0.142%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets22,996$0.35M0.0%+40.4%0.098%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.11,709$0.18M0.0%-10.8%0.050%Search for SEC Filing on Google Icon
1/26/2024Cerity Partners LLC125,226$1.88M0.0%N/A0.534%Search for SEC Filing on Google Icon
1/25/2024Allspring Global Investments Holdings LLC4,955$74K0.0%+31.6%0.021%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.3,575$54K0.0%+361.9%0.015%Search for SEC Filing on Google Icon
1/17/2024ARK Investment Management LLC161,525$2.42M0.0%-25.0%0.689%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC8,707$0.13M0.0%N/A0.037%Search for SEC Filing on Google Icon
11/15/2023Annandale Capital LLC81,831$1.15M0.3%-3.0%0.349%Search for SEC Filing on Google Icon
11/15/2023RA Capital Management L.P.1,483,697$20.79M0.4%N/A6.327%Search for SEC Filing on Google Icon
11/15/2023Laurion Capital Management LP380,600$5.33M0.0%+3.1%1.623%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC130,200$1.82M0.0%N/A0.555%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.29,766$0.42M0.0%+38.4%0.127%Search for SEC Filing on Google Icon
11/13/2023EAM Investors LLC170,523$2.39M0.5%N/A0.727%Search for SEC Filing on Google Icon
11/13/2023Federated Hermes Inc.13,130$0.18M0.0%N/A0.056%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC4,563$63K0.0%-36.5%0.019%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC508,883$7.13M2.2%N/A2.170%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC29,600$0.42M0.0%N/A0.126%Search for SEC Filing on Google Icon
11/6/2023Clal Insurance Enterprises Holdings Ltd222,159$3.11M0.0%-58.0%0.947%Search for SEC Filing on Google Icon
11/2/2023Rice Hall James & Associates LLC75,180$1.05M0.1%-1.2%0.321%Search for SEC Filing on Google Icon
10/30/2023Harel Insurance Investments & Financial Services Ltd.870,194$12.19M0.2%-15.1%3.711%Search for SEC Filing on Google Icon
10/30/2023Meitav Investment House Ltd.91,456$1.30M0.0%-13.3%0.390%Search for SEC Filing on Google Icon
10/27/2023Allspring Global Investments Holdings LLC3,764$53K0.0%N/A0.016%Search for SEC Filing on Google Icon
10/25/2023Migdal Insurance & Financial Holdings Ltd.648,302$9.08M0.2%-7.2%2.765%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp57,806$0.81M0.0%+25.9%0.247%Search for SEC Filing on Google Icon
10/20/2023Denali Advisors LLC14,300$0.20M0.1%-24.7%0.061%Search for SEC Filing on Google Icon
10/18/2023ARK Investment Management LLC215,272$3.02M0.0%+6.6%0.918%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC3,901$41K0.0%-52.1%0.017%Search for SEC Filing on Google Icon
8/17/2023Coastal Bridge Advisors LLC37,732$0.39M0.1%+2.0%0.161%Search for SEC Filing on Google Icon
8/16/2023Stonepine Capital Management LLC448,508$4.64M1.7%-36.1%1.913%Search for SEC Filing on Google Icon
8/14/2023Vivaldi Capital Management LP11,500$0.12M0.0%N/A0.049%Search for SEC Filing on Google Icon
8/14/2023Partners Capital Investment Group LLP15,384$0.16M0.0%N/A0.066%Search for SEC Filing on Google Icon
8/11/2023Stonepine Capital Management LLC448,508$4.64M1.7%-36.1%1.972%Search for SEC Filing on Google Icon
8/10/2023Meitav Investment House Ltd.105,512$1.11M0.0%-1.6%0.464%Search for SEC Filing on Google Icon
8/8/2023AlphaCentric Advisors LLC152,500$1.58M0.9%N/A0.671%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC7,187$74K0.0%+57.5%0.032%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.9,417$97K0.0%N/A0.041%Search for SEC Filing on Google Icon
7/31/2023Menora Mivtachim Holdings LTD.2,529,820$26.18M0.2%-13.3%11.125%Search for SEC Filing on Google Icon
7/24/2023Rice Hall James & Associates LLC76,087$0.79M0.0%+3.9%0.335%Search for SEC Filing on Google Icon
7/24/2023Meitav Investment House Ltd.105,512$1.11M0.0%-1.6%0.464%Search for SEC Filing on Google Icon
7/18/2023Denali Advisors LLC19,000$0.20M0.1%N/A0.084%Search for SEC Filing on Google Icon
7/10/2023ARK Investment Management LLC201,918$2.09M0.0%-25.4%0.888%Search for SEC Filing on Google Icon
5/16/2023Great Point Partners LLC39,222$0.36M0.1%-93.0%0.172%Search for SEC Filing on Google Icon
5/15/2023Stonepine Capital Management LLC701,535$6.48M2.2%-46.2%3.085%Search for SEC Filing on Google Icon
5/11/2023Meitav Investment House Ltd.107,212$1.25M0.0%-21.6%0.471%Search for SEC Filing on Google Icon
4/21/2023Bender Robert & Associates34,701$0.32M0.1%N/A0.153%Search for SEC Filing on Google Icon
4/20/2023Shikiar Asset Management Inc.33,250$0.31M0.1%N/A0.146%Search for SEC Filing on Google Icon
4/17/2023ARK Investment Management LLC270,746$2.50M0.0%+37.5%1.191%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC22,604$0.20M0.0%N/A0.099%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP31,046$0.28M0.0%-36.9%0.137%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
UroGen Pharma logo
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer (NMIBC). It is also developing UGN-301 for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; strategic research collaboration agreement with MD Anderson focusing on the sequential use of UGN-201 and UGN-301 for the treatment of NMIBC; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 in low-grade intermediate risk NMIBC and UGN-104 in low-grade upper tract urothelial carcinoma. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
Read More on UroGen Pharma

Today's Range

Now: $11.86
Low: $11.76
High: $12.34

50 Day Range

MA: $12.67
Low: $11.89
High: $13.85

52 Week Range

Now: $11.86
Low: $10.60
High: $20.70

Volume

362,957 shs

Average Volume

500,165 shs

Market Capitalization

$278.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Who are the company insiders with the largest holdings of UroGen Pharma?

UroGen Pharma's top insider investors include:
  1. Mark Schoenberg (Insider)
  2. Jason Drew Smith (General Counsel)
Learn More about top insider investors at UroGen Pharma.

Who are the major institutional investors of UroGen Pharma?

UroGen Pharma's top institutional investors include:
  1. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 5.72%
  2. Great Point Partners LLC — 3.24%
  3. Vestal Point Capital LP — 1.71%
  4. Stonepine Capital Management LLC — 1.20%
  5. Rice Hall James & Associates LLC — 1.16%
  6. ARK Investment Management LLC — 0.52%
Learn More about top institutional investors of UroGen Pharma stock.

Which institutional investors are selling UroGen Pharma stock?

In the last quarter, URGN stock was sold by these institutional investors:
  1. Great Point Partners LLC
  2. ARK Investment Management LLC
  3. Oak Ridge Investments LLC
Within the previous year, company insiders that have sold UroGen Pharma company stock include:
  1. Mark Schoenberg (Insider)
  2. Jason Drew Smith (General Counsel)
Learn More investors selling UroGen Pharma stock.

Which institutional investors are buying UroGen Pharma stock?

Within the last quarter, URGN stock was purchased by institutional investors including:
  1. Vestal Point Capital LP
  2. Stonepine Capital Management LLC
  3. Rice Hall James & Associates LLC
  4. Wesbanco Bank Inc.
  5. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  6. FMR LLC
  7. GSA Capital Partners LLP
  8. SG Americas Securities LLC